Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 315

1.

Telomere length tracking in children and their parents: implications for adult onset diseases.

Benetos A, Verhulst S, Labat C, Lai TP, Girerd N, Toupance S, Zannad F, Rossignol P, Aviv A.

FASEB J. 2019 Dec;33(12):14248-14253. doi: 10.1096/fj.201901275R. Epub 2019 Oct 25.

PMID:
31652401
2.

Newly diagnosed myeloma patients with low-burden disease may benefit from tandem autologous stem cell transplantation: results of long-term follow-up.

Benyamini N, Lavi N, Zuckerman T, Aviv A, Rowe JM, Katz T.

Bone Marrow Transplant. 2019 Sep 16. doi: 10.1038/s41409-019-0671-5. [Epub ahead of print] No abstract available.

PMID:
31527816
3.

Epigenome-wide association study of leukocyte telomere length.

Lee Y, Sun D, Ori APS, Lu AT, Seeboth A, Harris SE, Deary IJ, Marioni RE, Soerensen M, Mengel-From J, Hjelmborg J, Christensen K, Wilson JG, Levy D, Reiner AP, Chen W, Li S, Harris JR, Magnus P, Aviv A, Jugessur A, Horvath S.

Aging (Albany NY). 2019 Aug 26;11(16):5876-5894. doi: 10.18632/aging.102230. Epub 2019 Aug 26.

4.

DNA methylation-based estimator of telomere length.

Lu AT, Seeboth A, Tsai PC, Sun D, Quach A, Reiner AP, Kooperberg C, Ferrucci L, Hou L, Baccarelli AA, Li Y, Harris SE, Corley J, Taylor A, Deary IJ, Stewart JD, Whitsel EA, Assimes TL, Chen W, Li S, Mangino M, Bell JT, Wilson JG, Aviv A, Marioni RE, Raj K, Horvath S.

Aging (Albany NY). 2019 Aug 18;11(16):5895-5923. doi: 10.18632/aging.102173. Epub 2019 Aug 18.

5.

Smoking does not accelerate leucocyte telomere attrition: a meta-analysis of 18 longitudinal cohorts.

Bateson M, Aviv A, Bendix L, Benetos A, Ben-Shlomo Y, Bojesen SE, Cooper C, Cooper R, Deary IJ, Hägg S, Harris SE, Kark JD, Kronenberg F, Kuh D, Labat C, Martin-Ruiz CM, Meyer C, Nordestgaard BG, Penninx BWJH, Pepper GV, Révész D, Said MA, Starr JM, Syddall H, Thomson WM, van der Harst P, Whooley M, von Zglinicki T, Willeit P, Zhan Y, Nettle D.

R Soc Open Sci. 2019 Jun 5;6(6):190420. doi: 10.1098/rsos.190420. eCollection 2019 Jun.

6.

A new risk model to predict time to first treatment in chronic lymphocytic leukemia based on heavy chain immunoparesis and summated free light chain.

Tadmor T, Braester A, Najib D, Aviv A, Herishanu Y, Yuklea M, Shvidel L, Rahimi-Levene N, Ruchlemer R, Arad A, Fogl C, Henig C, Barak M, Magal L, Polliack A, Townsend K; Israeli CLL study group.

Eur J Haematol. 2019 Oct;103(4):335-341. doi: 10.1111/ejh.13288. Epub 2019 Jul 26.

PMID:
31278876
7.

Primary peg-filgrastim prophylaxis versus filgrastim given "on demand" for neutropenia during therapy with cladribine for hairy cell leukemia.

Tadmor T, Levy I, Herishanu Y, Goldschmidt N, Bairey O, Yuklea M, Shvidel L, Fineman R, Aviv A, Ruchlemer R, Braester A, Dally N, Rouvio O, Shaulov A, Greenbaum U, Inbar M, Polliack A.

Leuk Res. 2019 Jul;82:24-28. doi: 10.1016/j.leukres.2019.05.006. Epub 2019 May 19.

PMID:
31152919
8.
9.

Clonal Hematopoiesis Confers Predisposition to Both Cardiovascular Disease and Cancer.

Aviv A.

Ann Intern Med. 2019 Mar 5;170(5):356. doi: 10.7326/L18-0637. No abstract available.

PMID:
30831585
10.

Low-dose fludarabine and cyclophosphamide combined with standard dose rituximab (LD-FCR) is an effective and safe regimen for elderly untreated patients with chronic lymphocytic leukemia: The Israeli CLL study group experience.

Herishanu Y, Tadmor T, Braester A, Bairey O, Aviv A, Rahimi-Levene N, Fineman R, Levi I, Yuklea M, Ruchlemer R, Shvidel L, Polliack A.

Hematol Oncol. 2019 Apr;37(2):185-192. doi: 10.1002/hon.2580. Epub 2019 Mar 12.

PMID:
30756414
11.

DNA methylation GrimAge strongly predicts lifespan and healthspan.

Lu AT, Quach A, Wilson JG, Reiner AP, Aviv A, Raj K, Hou L, Baccarelli AA, Li Y, Stewart JD, Whitsel EA, Assimes TL, Ferrucci L, Horvath S.

Aging (Albany NY). 2019 Jan 21;11(2):303-327. doi: 10.18632/aging.101684.

12.

Paternal Age and Transgenerational Telomere Length Maintenance: A Simulation Model.

Horvath K, Eisenberg D, Stone R, Anderson J, Kark J, Aviv A.

Sci Rep. 2019 Jan 10;9(1):20. doi: 10.1038/s41598-018-36923-x.

13.

A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activity.

Michelis R, Tadmor T, Barhoum M, Shehadeh M, Shvidel L, Aviv A, Stemer G, Dally N, Rahimi-Levene N, Yuklea M, Braester A.

PLoS One. 2019 Jan 2;14(1):e0209024. doi: 10.1371/journal.pone.0209024. eCollection 2019.

14.

Hemothelium, Clonal Hematopoiesis of Indeterminate Potential, and Atherosclerosis.

Aviv A, Levy D.

Circulation. 2019 Jan 2;139(1):7-9. doi: 10.1161/CIRCULATIONAHA.118.038434. No abstract available.

PMID:
30592656
15.

Rapid shortening of leukocyte telomeres is associated with poorer pulmonary function among healthy adults.

Desai K, Berkman N, Cohen-Manheim I, Sinnreich R, Aviv A, Kark JD.

Respir Med. 2018 Dec;145:73-79. doi: 10.1016/j.rmed.2018.10.026. Epub 2018 Oct 25.

PMID:
30509719
16.

Hairy Cell Leukemia: Retrospective Analysis of Demographic Data and Outcome of 203 Patients from 12 Medical Centers in Israel.

Inbar M, Herishanu Y, Goldschmidt N, Bairey O, Yuklea M, Shvidel L, Fineman R, Aviv A, Ruchlemer R, Braester A, Najib D, Rouvio O, Shaulov A, Greenbaum U, Polliack A, Tadmor T.

Anticancer Res. 2018 Nov;38(11):6423-6429. doi: 10.21873/anticanres.13003.

PMID:
30396967
17.

Epigenetic clock for skin and blood cells applied to Hutchinson Gilford Progeria Syndrome and ex vivo studies.

Horvath S, Oshima J, Martin GM, Lu AT, Quach A, Cohen H, Felton S, Matsuyama M, Lowe D, Kabacik S, Wilson JG, Reiner AP, Maierhofer A, Flunkert J, Aviv A, Hou L, Baccarelli AA, Li Y, Stewart JD, Whitsel EA, Ferrucci L, Matsuyama S, Raj K.

Aging (Albany NY). 2018 Jul 26;10(7):1758-1775. doi: 10.18632/aging.101508.

18.

Outcomes of second-line treatment after fludarabine cyclophosphamide and rituximab in patients with chronic lymphocytic leukemia outside clinical trials.

Joffe E, Goldschmidt N, Bairey O, Fineman R, Ruchlemer R, Rahimi-Levene N, Shvidel L, Greenbaum U, Aviv A, Tadmor T, Braester A, Arad A, Polliack A, Herishanu Y; Israeli CLL Study Group.

Eur J Haematol. 2018 Sep;101(3):399-406. doi: 10.1111/ejh.13129. Epub 2018 Aug 3.

PMID:
29949186
19.

Plasmapheresis in a Patient with Sarcoidosis Who Developed Multiple Myeloma and Massive Free Kappa Light Chains Nephropathy.

Markel A, Habashe N, Aviv A, Monich O, Elmalah I, Marei N, Tovbin D.

Isr Med Assoc J. 2018 May;20(5):324-326. No abstract available.

20.

An epigenetic biomarker of aging for lifespan and healthspan.

Levine ME, Lu AT, Quach A, Chen BH, Assimes TL, Bandinelli S, Hou L, Baccarelli AA, Stewart JD, Li Y, Whitsel EA, Wilson JG, Reiner AP, Aviv A, Lohman K, Liu Y, Ferrucci L, Horvath S.

Aging (Albany NY). 2018 Apr 18;10(4):573-591. doi: 10.18632/aging.101414.

21.

Response by Benetos et al to Letter Regarding Article, "Short Leukocyte Telomere Length Precedes Clinical Expression of Atherosclerosis: The Blood-and-Muscle Model".

Benetos A, Kark JD, Toupance S, Verhulst S, Aviv A.

Circ Res. 2018 Apr 13;122(8):e73-e74. doi: 10.1161/CIRCRESAHA.118.312967. No abstract available.

22.

GWAS of epigenetic aging rates in blood reveals a critical role for TERT.

Lu AT, Xue L, Salfati EL, Chen BH, Ferrucci L, Levy D, Joehanes R, Murabito JM, Kiel DP, Tsai PC, Yet I, Bell JT, Mangino M, Tanaka T, McRae AF, Marioni RE, Visscher PM, Wray NR, Deary IJ, Levine ME, Quach A, Assimes T, Tsao PS, Absher D, Stewart JD, Li Y, Reiner AP, Hou L, Baccarelli AA, Whitsel EA, Aviv A, Cardona A, Day FR, Wareham NJ, Perry JRB, Ong KK, Raj K, Lunetta KL, Horvath S.

Nat Commun. 2018 Jan 26;9(1):387. doi: 10.1038/s41467-017-02697-5.

23.

The mitochondrial genome, paternal age and telomere length in humans.

Aviv A.

Philos Trans R Soc Lond B Biol Sci. 2018 Mar 5;373(1741). pii: 20170210. doi: 10.1098/rstb.2017.0210.

24.

Reflections on telomere dynamics and ageing-related diseases in humans.

Aviv A, Shay JW.

Philos Trans R Soc Lond B Biol Sci. 2018 Mar 5;373(1741). pii: 20160436. doi: 10.1098/rstb.2016.0436.

25.

Short Leukocyte Telomere Length Precedes Clinical Expression of Atherosclerosis: The Blood-and-Muscle Model.

Benetos A, Toupance S, Gautier S, Labat C, Kimura M, Rossi PM, Settembre N, Hubert J, Frimat L, Bertrand B, Boufi M, Flecher X, Sadoul N, Eschwege P, Kessler M, Tzanetakou IP, Doulamis IP, Konstantopoulos P, Tzani A, Korou M, Gkogkos A, Perreas K, Menenakos E, Samanidis G, Vasiloglou-Gkanis M, Kark JD, Malikov S, Verhulst S, Aviv A.

Circ Res. 2018 Feb 16;122(4):616-623. doi: 10.1161/CIRCRESAHA.117.311751. Epub 2017 Dec 14.

26.

A null mutation in SERPINE1 protects against biological aging in humans.

Khan SS, Shah SJ, Klyachko E, Baldridge AS, Eren M, Place AT, Aviv A, Puterman E, Lloyd-Jones DM, Heiman M, Miyata T, Gupta S, Shapiro AD, Vaughan DE.

Sci Adv. 2017 Nov 15;3(11):eaao1617. doi: 10.1126/sciadv.aao1617. eCollection 2017 Nov.

27.

Environmental Exposures, Telomere Length at Birth, and Disease Susceptibility in Later Life.

Factor-Litvak P, Susser E, Aviv A.

JAMA Pediatr. 2017 Dec 1;171(12):1143-1144. doi: 10.1001/jamapediatrics.2017.3562. No abstract available.

28.

Leukocyte telomere length and cardiovascular disease in African Americans: The Jackson Heart Study.

Mwasongwe S, Gao Y, Griswold M, Wilson JG, Aviv A, Reiner AP, Raffield LM.

Atherosclerosis. 2017 Nov;266:41-47. doi: 10.1016/j.atherosclerosis.2017.09.016. Epub 2017 Sep 15.

29.

Leukocyte telomere length, T cell composition and DNA methylation age.

Chen BH, Carty CL, Kimura M, Kark JD, Chen W, Li S, Zhang T, Kooperberg C, Levy D, Assimes T, Absher D, Horvath S, Reiner AP, Aviv A.

Aging (Albany NY). 2017 Sep 20;9(9):1983-1995. doi: 10.18632/aging.101293.

30.

Telomere length dynamics in early life: the blood-and-muscle model.

Sabharwal S, Verhulst S, Guirguis G, Kark JD, Labat C, Roche NE, Martimucci K, Patel K, Heller DS, Kimura M, Chuang D, Chuang A, Benetos A, Aviv A.

FASEB J. 2018 Jan;32(1):529-534. doi: 10.1096/fj.201700630R. Epub 2017 Aug 29.

31.

Correlation of Leukocyte Telomere Length Measurement Methods in Patients with Dyskeratosis Congenita and in Their Unaffected Relatives.

Khincha PP, Dagnall CL, Hicks B, Jones K, Aviv A, Kimura M, Katki H, Aubert G, Giri N, Alter BP, Savage SA, Gadalla SM.

Int J Mol Sci. 2017 Aug 13;18(8). pii: E1765. doi: 10.3390/ijms18081765.

32.

Telomere Length and Risk of Cancer and Non-neoplastic Diseases: Is Survivin the Ariadne's Thread?-Reply.

Haycock PC, Hemani G, Aviv A.

JAMA Oncol. 2017 Dec 1;3(12):1741-1742. doi: 10.1001/jamaoncol.2017.2316. No abstract available.

PMID:
28796865
33.

Mutations, Cancer and the Telomere Length Paradox.

Aviv A, Anderson JJ, Shay JW.

Trends Cancer. 2017 Apr;3(4):253-258. doi: 10.1016/j.trecan.2017.02.005. Epub 2017 Mar 27. Review.

34.

Persistently low lymphocyte counts after FCR therapy for chronic lymphocytic leukemia are associated with longer overall survival.

Joffe E, Ariela Arad N, Bairey O, Fineman R, Ruchlemer R, Rahimi-Levene N, Shvidel L, Greenbaum U, Aviv A, Tadmor T, Braester A, Goldschmidt N, Polliack A, Herishanu Y.

Hematol Oncol. 2018 Feb;36(1):128-135. doi: 10.1002/hon.2444. Epub 2017 Jun 22.

PMID:
28639416
35.

Short Telomeres, but Not Telomere Attrition Rates, Are Associated With Carotid Atherosclerosis.

Toupance S, Labat C, Temmar M, Rossignol P, Kimura M, Aviv A, Benetos A.

Hypertension. 2017 Aug;70(2):420-425. doi: 10.1161/HYPERTENSIONAHA.117.09354. Epub 2017 Jun 19.

36.

Ancestry, Telomere Length, and Atherosclerosis Risk.

Benetos A, Aviv A.

Circ Cardiovasc Genet. 2017 Jun;10(3). pii: e001718. doi: 10.1161/CIRCGENETICS.117.001718. Review. No abstract available.

37.

Telomeres and the natural lifespan limit in humans.

Steenstrup T, Kark JD, Verhulst S, Thinggaard M, Hjelmborg JVB, Dalgård C, Kyvik KO, Christiansen L, Mangino M, Spector TD, Petersen I, Kimura M, Benetos A, Labat C, Sinnreich R, Hwang SJ, Levy D, Hunt SC, Fitzpatrick AL, Chen W, Berenson GS, Barbieri M, Paolisso G, Gadalla SM, Savage SA, Christensen K, Yashin AI, Arbeev KG, Aviv A.

Aging (Albany NY). 2017 Apr;9(4):1130-1142. doi: 10.18632/aging.101216.

38.

Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study.

Telomeres Mendelian Randomization Collaboration, Haycock PC, Burgess S, Nounu A, Zheng J, Okoli GN, Bowden J, Wade KH, Timpson NJ, Evans DM, Willeit P, Aviv A, Gaunt TR, Hemani G, Mangino M, Ellis HP, Kurian KM, Pooley KA, Eeles RA, Lee JE, Fang S, Chen WV, Law MH, Bowdler LM, Iles MM, Yang Q, Worrall BB, Markus HS, Hung RJ, Amos CI, Spurdle AB, Thompson DJ, O'Mara TA, Wolpin B, Amundadottir L, Stolzenberg-Solomon R, Trichopoulou A, Onland-Moret NC, Lund E, Duell EJ, Canzian F, Severi G, Overvad K, Gunter MJ, Tumino R, Svenson U, van Rij A, Baas AF, Bown MJ, Samani NJ, van t'Hof FNG, Tromp G, Jones GT, Kuivaniemi H, Elmore JR, Johansson M, Mckay J, Scelo G, Carreras-Torres R, Gaborieau V, Brennan P, Bracci PM, Neale RE, Olson SH, Gallinger S, Li D, Petersen GM, Risch HA, Klein AP, Han J, Abnet CC, Freedman ND, Taylor PR, Maris JM, Aben KK, Kiemeney LA, Vermeulen SH, Wiencke JK, Walsh KM, Wrensch M, Rice T, Turnbull C, Litchfield K, Paternoster L, Standl M, Abecasis GR, SanGiovanni JP, Li Y, Mijatovic V, Sapkota Y, Low SK, Zondervan KT, Montgomery GW, Nyholt DR, van Heel DA, Hunt K, Arking DE, Ashar FN, Sotoodehnia N, Woo D, Rosand J, Comeau ME, Brown WM, Silverman EK, Hokanson JE, Cho MH, Hui J, Ferreira MA, Thompson PJ, Morrison AC, Felix JF, Smith NL, Christiano AM, Petukhova L, Betz RC, Fan X, Zhang X, Zhu C, Langefeld CD, Thompson SD, Wang F, Lin X, Schwartz DA, Fingerlin T, Rotter JI, Cotch MF, Jensen RA, Munz M, Dommisch H, Schaefer AS, Han F, Ollila HM, Hillary RP, Albagha O, Ralston SH, Zeng C, Zheng W, Shu XO, Reis A, Uebe S, Hüffmeier U, Kawamura Y, Otowa T, Sasaki T, Hibberd ML, Davila S, Xie G, Siminovitch K, Bei JX, Zeng YX, Försti A, Chen B, Landi S, Franke A, Fischer A, Ellinghaus D, Flores C, Noth I, Ma SF, Foo JN, Liu J, Kim JW, Cox DG, Delattre O, Mirabeau O, Skibola CF, Tang CS, Garcia-Barcelo M, Chang KP, Su WH, Chang YS, Martin NG, Gordon S, Wade TD, Lee C, Kubo M, Cha PC, Nakamura Y, Levy D, Kimura M, Hwang SJ, Hunt S, Spector T, Soranzo N, Manichaikul AW, Barr RG, Kahali B, Speliotes E, Yerges-Armstrong LM, Cheng CY, Jonas JB, Wong TY, Fogh I, Lin K, Powell JF, Rice K, Relton CL, Martin RM, Davey Smith G.

JAMA Oncol. 2017 May 1;3(5):636-651. doi: 10.1001/jamaoncol.2016.5945.

39.

Response to: Reliability and validity of telomere length measurements.

Verhulst S, Susser E, Factor-Litvak PR, Simons M, Benetos A, Steenstrup T, Kark JD, Aviv A.

Int J Epidemiol. 2016 Aug;45(4):1298-1301. No abstract available.

40.

Positive Association Between Vitamin D Serum Levels and Naevus Counts.

Ribero S, Glass D, Mangino M, Aviv A, Spector T, Bataille V.

Acta Derm Venereol. 2017 Mar 10;97(3):321-324. doi: 10.2340/00015555-2583.

41.

Non-Dynamic Association of Depressive and Anxiety Disorders With Leukocyte Telomere Length?

Susser E, Verhulst S, Kark JD, Factor-Litvak PR, Keyes K, Magnus P, Aviv A.

Am J Psychiatry. 2016 Nov 1;173(11):1147. No abstract available.

42.

Neutrophil-lymphocyte ratio at diagnosis is an independent prognostic factor in patients with nodular sclerosis Hodgkin lymphoma: results of a large multicenter study involving 990 patients.

Marcheselli R, Bari A, Tadmor T, Marcheselli L, Cox MC, Pozzi S, Ferrari A, Baldini L, Gobbi P, Aviv A, Pugliese G, Federico M, Polliack A, Sacchi S.

Hematol Oncol. 2017 Dec;35(4):561-566. doi: 10.1002/hon.2359. Epub 2016 Oct 28.

43.

Shorter telomere length in Europeans than in Africans due to polygenetic adaptation.

Hansen ME, Hunt SC, Stone RC, Horvath K, Herbig U, Ranciaro A, Hirbo J, Beggs W, Reiner AP, Wilson JG, Kimura M, De Vivo I, Chen MM, Kark JD, Levy D, Nyambo T, Tishkoff SA, Aviv A.

Hum Mol Genet. 2016 Jun 1;25(11):2324-2330. Epub 2016 Mar 2.

44.

Acne and Telomere Length: A New Spectrum between Senescence and Apoptosis Pathways.

Ribero S, Sanna M, Visconti A, Navarini A, Aviv A, Glass D, Spector TD, Smith C, Simpson M, Barker J, Mangino M, Falchi M, Bataille V.

J Invest Dermatol. 2017 Feb;137(2):513-515. doi: 10.1016/j.jid.2016.09.014. Epub 2016 Sep 28. No abstract available.

45.

Telomere Length and the Cancer-Atherosclerosis Trade-Off.

Stone RC, Horvath K, Kark JD, Susser E, Tishkoff SA, Aviv A.

PLoS Genet. 2016 Jul 7;12(7):e1006144. doi: 10.1371/journal.pgen.1006144. eCollection 2016 Jul. Review.

46.

Telomere length measurement by a novel Luminex-based assay: a blinded comparison to Southern blot.

Pierce BL, Jasmine F, Roy S, Zhang C, Aviv A, Hunt SC, Ahsan H, Kibriya MG.

Int J Mol Epidemiol Genet. 2016 Mar 23;7(1):18-23. eCollection 2016.

47.

A short leucocyte telomere length is associated with development of insulin resistance.

Verhulst S, Dalgård C, Labat C, Kark JD, Kimura M, Christensen K, Toupance S, Aviv A, Kyvik KO, Benetos A.

Diabetologia. 2016 Jun;59(6):1258-65. doi: 10.1007/s00125-016-3915-6. Epub 2016 Mar 28.

PMID:
27020448
48.

Leukocyte Telomere Length in Newborns: Implications for the Role of Telomeres in Human Disease.

Factor-Litvak P, Susser E, Kezios K, McKeague I, Kark JD, Hoffman M, Kimura M, Wapner R, Aviv A.

Pediatrics. 2016 Apr;137(4). pii: e20153927. doi: 10.1542/peds.2015-3927. Epub 2016 Mar 11.

49.

DNA methylation age is associated with mortality in a longitudinal Danish twin study.

Christiansen L, Lenart A, Tan Q, Vaupel JW, Aviv A, McGue M, Christensen K.

Aging Cell. 2016 Feb;15(1):149-54. doi: 10.1111/acel.12421. Epub 2015 Nov 17.

50.

The transcriptional landscape of age in human peripheral blood.

Peters MJ, Joehanes R, Pilling LC, Schurmann C, Conneely KN, Powell J, Reinmaa E, Sutphin GL, Zhernakova A, Schramm K, Wilson YA, Kobes S, Tukiainen T; NABEC/UKBEC Consortium, Ramos YF, Göring HH, Fornage M, Liu Y, Gharib SA, Stranger BE, De Jager PL, Aviv A, Levy D, Murabito JM, Munson PJ, Huan T, Hofman A, Uitterlinden AG, Rivadeneira F, van Rooij J, Stolk L, Broer L, Verbiest MM, Jhamai M, Arp P, Metspalu A, Tserel L, Milani L, Samani NJ, Peterson P, Kasela S, Codd V, Peters A, Ward-Caviness CK, Herder C, Waldenberger M, Roden M, Singmann P, Zeilinger S, Illig T, Homuth G, Grabe HJ, Völzke H, Steil L, Kocher T, Murray A, Melzer D, Yaghootkar H, Bandinelli S, Moses EK, Kent JW, Curran JE, Johnson MP, Williams-Blangero S, Westra HJ, McRae AF, Smith JA, Kardia SL, Hovatta I, Perola M, Ripatti S, Salomaa V, Henders AK, Martin NG, Smith AK, Mehta D, Binder EB, Nylocks KM, Kennedy EM, Klengel T, Ding J, Suchy-Dicey AM, Enquobahrie DA, Brody J, Rotter JI, Chen YD, Houwing-Duistermaat J, Kloppenburg M, Slagboom PE, Helmer Q, den Hollander W, Bean S, Raj T, Bakhshi N, Wang QP, Oyston LJ, Psaty BM, Tracy RP, Montgomery GW, Turner ST, Blangero J, Meulenbelt I, Ressler KJ, Yang J, Franke L, Kettunen J, Visscher PM, Neely GG, Korstanje R, Hanson RL, Prokisch H, Ferrucci L, Esko T, Teumer A, van Meurs JB, Johnson AD.

Nat Commun. 2015 Oct 22;6:8570. doi: 10.1038/ncomms9570.

Supplemental Content

Support Center